Method for the intranasal administration of 3-[2-(dimethylamino)-ethyl]-H-methyl-1H-indole-5-methanesulphonamide
AssigneeGlaxo Group Limited
InventorsJoanne Craig, David A. Saynor
Life of this patent
Estimating the term…
Abstract
A method of treating a human suffering from or susceptable to cephalic pain by intramasally administering 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indol-5-methanesulphonamide in a pH range of from 9-11.
Claims16
A method of treating a human suffering from or susceptible to cephalic pain which comprises intranasal administration of a pharmaceutical composition which comprises an aqueous suspension of 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide in the form of the free base or a suitable physiologically acceptable solvate thereof as active ingredient, wherein the pH of the aqueous suspension is in the range of 9 to 11.
A method of treating a human suffering from or susceptible to migraine which comprises intranasal administration of a pharmaceutical composition which comprises an aqueous suspension of 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide in the form of the free base or a suitable physiologically acceptable solvate thereof as active ingredient, wherein the pH of the aqueous suspension is in the range of 9 to 11.
Dependencies are inferred from the claim text.